Search filters

List of works by Julien Taïeb

5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer

scientific article

A novel dendritic cell subset involved in tumor immunosurveillance

scientific article published on 29 January 2006

Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives

scientific article

Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice

scientific article published on 2 May 2016

An unusual recurrence site for HCC!

scientific article published on 4 July 2012

Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy

scientific article published on March 2011

Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients

scientific article published on 17 February 2016

Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9).

scientific article published on 18 January 2018

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

scientific article published on 6 June 2013

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

scientific article

Case histories in unresectable liver-dominant metastatic colorectal cancer

scientific article

Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial

scientific article

Checkpoint inhibitors and gastrointestinal immune-related adverse events

scientific article published on 30 June 2016

Chemosensitivity in ovarian metastases from gastric cancer: a case series

scientific article published on 9 November 2012

Colorectal cancer and immunity: what we know and perspectives

scientific article published on April 2014

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer

scientific article

Control of the immune response by pro-angiogenic factors

scientific article

DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical Trial

scientific article published on 21 January 2016

Dendritic cell derived-exosomes: biology and clinical implementations

scientific article published on 29 June 2006

Dendritic cell-derived exosomes as cell-free peptide-based vaccines

scientific article

Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha

scientific article

Digestive neuroendocrine tumors (DNET): the era of targeted therapies

scientific article published on 03 April 2013

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy

scientific article

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study

scientific article published on February 2016

Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study

scientific article published on 29 December 2015

Exosome-based immunotherapy

scientific article published on 16 January 2004

Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection

scientific article published on February 2004

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study.

scientific article published on 8 December 2006

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

scientific article published on 6 May 2016

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

scientific article

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 tri

scientific article published on 03 August 2017

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study

scientific article

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study

scientific article

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

scientific article

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study

scientific article

Hepatocellular carcinoma (HCC): an update

scientific article published on April 2007

Immunity and squamous cell carcinoma of the anus: epidemiological, clinical and therapeutic aspects

scientific article published on 08 August 2013

Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study

scientific article

Lessons from Tarceva in pancreatic cancer: where are we now, and how should future trials be designed in pancreatic cancer?

scientific article published on July 2008

Management of hepatocellular carcinoma. Where are we now? What's next?

scientific article published in January 2009

Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine

scientific article published on 23 March 2011

Modulation of immunity by antiangiogenic molecules in cancer

scientific article published on 24 December 2012

Mucosal imprinting of vaccine-induced CD8⁺ T cells is crucial to inhibit the growth of mucosal tumors

scientific article

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial

scientific article

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

scientific article

Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial

scientific article published on 10 July 2015

Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

scientific article published on May 2011

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

scientific article published on August 2004

Operable colon cancer: initial strategy

scientific article published on October 20, 2010

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

scientific article

Pathologic Major Response After FOLFIRINOX is Prognostic for Patients Secondary Resected for Borderline or Locally Advanced Pancreatic Adenocarcinoma: An AGEO-FRENCH, Prospective, Multicentric Cohort

scientific article published on 14 August 2015

Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).

scientific article

Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer

scientific article

Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer

scientific article published on 31 December 2016

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

scientific article published on 6 October 2014

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.

scientific article published on 23 June 2017

Reply to the comment on 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'.

scientific article published on 28 April 2016

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials

scientific article published on 5 October 2017

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

scientific article published on 22 February 2016

Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial

scientific article published on 26 May 2015

Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays

scientific article (publication date: 18 January 2011)

Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge

scientific article

Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study

scientific article published on 5 November 2013

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

scientific article published on 09 January 2014

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy

scientific article

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy

scientific article

The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cancer: Current Status

scientific article published in September 2014

The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2.

scientific article published in May 2008

The potential of exosomes in immunotherapy

scientific article

The potential of exosomes in immunotherapy of cancer

scientific article

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells

scientific article published on February 2007

Trastuzumab in Combination with FOLFIRI in Patients with Advanced HER2-Positive Gastro-Esophageal Adenocarcinoma: A Retrospective Multicenter AGEO Study

scientific article

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer

scientific article published on 18 July 2013

Unresectable liver metastases in colorectal cancer: review of current strategies

scientific article

VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors

scientific article

VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer

scientific article

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer

scientific article published on 10 June 2013

Paulina is supported by:

About Paulina

Help